These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 36381886)

  • 1. Measures to Mitigate Sodium Valproate Use in Pregnant Women With Epilepsy.
    Ranjith S; Joshi A
    Cureus; 2022 Oct; 14(10):e30144. PubMed ID: 36381886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sodium valproate in pregnancy: what are the risks and should we use a shared decision-making approach?
    Macfarlane A; Greenhalgh T
    BMC Pregnancy Childbirth; 2018 Jun; 18(1):200. PubMed ID: 29859057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. National compliance with UK wide guidelines for usage of valproate in women of childbearing potential.
    Eriksson SH; Tittensor P; Sisodiya SM
    Seizure; 2022 May; 98():8-12. PubMed ID: 35395505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are female bipolar patients of reproductive age aware of the teratogenic risk of sodium valproate? A qualitative study.
    Sibanyoni AU; Joubert M; Naidu K
    S Afr J Psychiatr; 2022; 28():1719. PubMed ID: 35169512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-sectional evaluation of prescription of valproate and other antiepileptic drugs to pregnant women.
    Aykan DA; Ergün Y
    Acta Neurol Belg; 2021 Apr; 121(2):503-508. PubMed ID: 31659713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prescription of Sodium Valproate as a Mood Stabiliser in Pregnancy.
    Womersley K
    Psychiatr Danub; 2017 Sep; 29(Suppl 3):679-684. PubMed ID: 28953852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A UK clinical audit addressing the quality of prescribing of sodium valproate for bipolar disorder in women of childbearing age.
    Paton C; Cookson J; Ferrier IN; Bhatti S; Fagan E; Barnes TRE
    BMJ Open; 2018 Apr; 8(4):e020450. PubMed ID: 29654033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Valproate in the treatment of epilepsy in girls and women of childbearing potential.
    Tomson T; Marson A; Boon P; Canevini MP; Covanis A; Gaily E; Kälviäinen R; Trinka E
    Epilepsia; 2015 Jul; 56(7):1006-19. PubMed ID: 25851171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Valproate prescription to women of childbearing age in English primary care: repeated cross-sectional analyses and retrospective cohort study.
    Gaudio M; Konstantara E; Joy M; van Vlymen J; de Lusignan S
    BMC Pregnancy Childbirth; 2022 Jan; 22(1):73. PubMed ID: 35086478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 'Conceivably Neglected' - Are prescribers sufficiently aware of the risks of prescribing sodium valproate to women with mental illness?
    Perera C; Patterson S; Bruxner G
    Australas Psychiatry; 2019 Apr; 27(2):125-128. PubMed ID: 30763123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prescribing valproate to girls and women of childbearing age in Germany : Analysis of trends based on claims data].
    Wentzell N; Haug U; Schink T; Engel S; Liebentraut J; Linder R; Onken M; Schaefer C; Dathe K
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2018 Aug; 61(8):1022-1029. PubMed ID: 29922910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Status epilepticus in pregnant women with epilepsy after valproate adjustment: A case series.
    Wu M; Hao N; Yan B; Chi X; Zhou D
    Seizure; 2016 Dec; 43():39-41. PubMed ID: 27875769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism.
    Christensen J; Grønborg TK; Sørensen MJ; Schendel D; Parner ET; Pedersen LH; Vestergaard M
    JAMA; 2013 Apr; 309(16):1696-703. PubMed ID: 23613074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expert opinion: use of valproate in girls and women of childbearing potential with epilepsy: recommendations and alternatives based on a review of the literature and clinical experience-a European perspective.
    Toledo M; Mostacci B; Bosak M; Jedrzejzak J; Thomas RH; Salas-Puig J; Biraben A; Schmitz B
    J Neurol; 2021 Aug; 268(8):2735-2748. PubMed ID: 32239268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [French Expert advice on the management of valproate in childbearing and pregnant women with bipolar disorder].
    Samalin L; Arnould A; Boudieu L; Henry C; Haffen E; Drapier D; Anmella G; Pacchiarotti I; Vieta E; Belzeaux R; Llorca PM
    Encephale; 2022 Dec; 48(6):624-631. PubMed ID: 36257849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Valproate prescriptions for nonepilepsy disorders in reproductive-age women.
    Adedinsewo DA; Thurman DJ; Luo YH; Williamson RS; Odewole OA; Oakley GP
    Birth Defects Res A Clin Mol Teratol; 2013 Jun; 97(6):403-8. PubMed ID: 23733498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Valproate in Pregnancy: Recent Research and Regulatory Responses.
    Andrade C
    J Clin Psychiatry; 2018; 79(3):. PubMed ID: 29873961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact and challenges of the 2018 MHRA statement on the use of sodium valproate in women of childbearing age during the first year of implementation, in a UK epilepsy centre.
    Davies P; Reuber M; Grunewald R; Howell S; Dickson J; Dennis G; Shanmugarajah P; Tsironis T; Brockington A
    Seizure; 2020 Jul; 79():8-13. PubMed ID: 32380376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Awareness, knowledge and practice of healthcare professionals following implementation of a Pregnancy Prevention Program for sodium valproate in Ireland: a multi-stakeholder cross-sectional study.
    Hughes JE; Buckley N; Looney Y; Kirwan G; Curran S; Doherty CP; Mullooly M; Bennett KE
    Expert Opin Drug Saf; 2021 Aug; 20(8):965-977. PubMed ID: 34080507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risks of neurobehavioral teratogenicity associated with prenatal exposure to valproate monotherapy: a systematic review with regulatory repercussions.
    Gentile S
    CNS Spectr; 2014 Aug; 19(4):305-15. PubMed ID: 24571806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.